BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21637745)

  • 41. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.
    Permuth JB; Pirie A; Ann Chen Y; Lin HY; Reid BM; Chen Z; Monteiro A; Dennis J; Mendoza-Fandino G; ; ; Anton-Culver H; Bandera EV; Bisogna M; Brinton L; Brooks-Wilson A; Carney ME; Chenevix-Trench G; Cook LS; Cramer DW; Cunningham JM; Cybulski C; D'Aloisio AA; Anne Doherty J; Earp M; Edwards RP; Fridley BL; Gayther SA; Gentry-Maharaj A; Goodman MT; Gronwald J; Hogdall E; Iversen ES; Jakubowska A; Jensen A; Karlan BY; Kelemen LE; Kjaer SK; Kraft P; Le ND; Levine DA; Lissowska J; Lubinski J; Matsuo K; Menon U; Modugno R; Moysich KB; Nakanishi T; Ness RB; Olson S; Orlow I; Pearce CL; Pejovic T; Poole EM; Ramus SJ; Anne Rossing M; Sandler DP; Shu XO; Song H; Taylor JA; Teo SH; Terry KL; Thompson PJ; Tworoger SS; Webb PM; Wentzensen N; Wilkens LR; Winham S; Woo YL; Wu AH; Yang H; Zheng W; Ziogas A; Phelan CM; Schildkraut JM; Berchuck A; Goode EL; Pharoah PD; Sellers TA;
    Hum Mol Genet; 2016 Aug; 25(16):3600-3612. PubMed ID: 27378695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
    Palmieri RT; Wilson MA; Iversen ES; Clyde MA; Calingaert B; Moorman PG; Poole C; Anderson AR; Anderson S; Anton-Culver H; Beesley J; Hogdall E; Brewster W; Carney ME; Chen X; Chenevix-Trench G; Chang-Claude J; Cunningham JM; Dicioccio RA; Doherty JA; Easton DF; Edlund CK; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Kjaer SK; Hogdall CK; Hopkins MP; Jenison EL; Blaakaer J; Lurie G; McGuire V; Menon U; Moysich KB; Ness RB; Pearce CL; Pharoah PD; Pike MC; Ramus SJ; Rossing MA; Song H; Terada KY; Vandenberg D; Vierkant RA; Wang-Gohrke S; Webb PM; Whittemore AS; Wu AH; Ziogas A; Berchuck A; Schildkraut JM; ; ;
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3567-72. PubMed ID: 19064572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rare ATAD5 missense variants in breast and ovarian cancer patients.
    Maleva Kostovska I; Wang J; Bogdanova N; Schürmann P; Bhuju S; Geffers R; Dürst M; Liebrich C; Klapdor R; Christiansen H; Park-Simon TW; Hillemanns P; Plaseska-Karanfilska D; Dörk T
    Cancer Lett; 2016 Jun; 376(1):173-7. PubMed ID: 27045477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.
    Permuth-Wey J; Chen Z; Tsai YY; Lin HY; Chen YA; Barnholtz-Sloan J; Birrer MJ; Chanock SJ; Cramer DW; Cunningham JM; Fenstermacher D; Fridley BL; Garcia-Closas M; Gayther SA; Gentry-Maharaj A; Gonzalez-Bosquet J; Iversen E; Jim H; McLaughlin J; Menon U; Narod SA; Phelan CM; Ramus SJ; Risch H; Song H; Sutphen R; Terry KL; Tyrer J; Vierkant RA; Wentzensen N; Lancaster JM; Cheng JQ; Berchuck A; Pharoah PD; Schildkraut JM; Goode EL; Sellers TA;
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1793-7. PubMed ID: 21636674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.
    Koestler DC; Chalise P; Cicek MS; Cunningham JM; Armasu S; Larson MC; Chien J; Block M; Kalli KR; Sellers TA; Fridley BL; Goode EL
    BMC Med Genomics; 2014 Jan; 7():8. PubMed ID: 24479488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers.
    Beesley J; Pickett HA; Johnatty SE; Dunning AM; Chen X; Li J; Michailidou K; Lu Y; Rider DN; Palmieri RT; Stutz MD; Lambrechts D; Despierre E; Lambrechts S; Vergote I; Chang-Claude J; Nickels S; Vrieling A; Flesch-Janys D; Wang-Gohrke S; Eilber U; Bogdanova N; Antonenkova N; Runnebaum IB; Dörk T; Goodman MT; Lurie G; Wilkens LR; Matsuno RK; Kiemeney LA; Aben KK; Marees T; Massuger LF; Fridley BL; Vierkant RA; Bandera EV; Olson SH; Orlow I; Rodriguez-Rodriguez L; Cook LS; Le ND; Brooks-Wilson A; Kelemen LE; Campbell I; Gayther SA; Ramus SJ; Gentry-Maharaj A; Menon U; Ahmed S; Baynes C; Pharoah PD; ; ; ; Muir K; Lophatananon A; Chaiwerawattana A; Wiangnon S; Macgregor S; Easton DF; Reddel RR; Goode EL; Chenevix-Trench G;
    PLoS One; 2011; 6(9):e24987. PubMed ID: 21949822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
    Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
    Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic variants of lncRNA HOTAIR and risk of epithelial ovarian cancer among Chinese women.
    Wu H; Shang X; Shi Y; Yang Z; Zhao J; Yang M; Li Y; Xu S
    Oncotarget; 2016 Jul; 7(27):41047-41052. PubMed ID: 27166268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BRCA2 N372H Polymorphism and Risk of Epithelial Ovarian Cancer: An Updated Meta-Analysis With 2344 Cases and 9672 Controls.
    Su L; Wang J; Tao Y; Shao X; Ding Y; Cheng X; Zhu Y
    Medicine (Baltimore); 2015 Oct; 94(42):e1695. PubMed ID: 26496279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.
    Liu T; Chen L; Sun X; Wang Y; Li S; Yin X; Wang X; Ding C; Li H; Di W
    Tumour Biol; 2014 Mar; 35(3):2427-36. PubMed ID: 24197980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer.
    Ye Y; Yin M; Huang B; Wang Y; Li X; Lou G
    Tumour Biol; 2015 Jun; 36(6):4175-9. PubMed ID: 25582317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.
    Kan CW; Howell VM; Hahn MA; Marsh DJ
    Genes Chromosomes Cancer; 2015 Jan; 54(1):1-19. PubMed ID: 25280227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas.
    Tuhkanen H; Anttila M; Kosma VM; Heinonen S; Juhola M; Helisalmi S; Kataja V; Mannermaa A
    Int J Cancer; 2006 Sep; 119(6):1345-53. PubMed ID: 16642473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.
    Grant DJ; Hoyo C; Akushevich L; Iversen ES; Whitaker R; Marks J; Berchuck A; Schildkraut JM
    Gynecol Oncol; 2013 Apr; 129(1):173-8. PubMed ID: 23262379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.
    Chen K; Ma H; Li L; Zang R; Wang C; Song F; Shi T; Yu D; Yang M; Xue W; Dai J; Li S; Zheng H; Wu C; Zhang Y; Wu X; Li D; Xue F; Li H; Jiang Z; Liu J; Liu Y; Li P; Tan W; Han J; Jie J; Hao Q; Hu Z; Lin D; Ma D; Jia W; Shen H; Wei Q
    Nat Commun; 2014 Aug; 5():4682. PubMed ID: 25134534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
    Mercier PL; Bachvarova M; Plante M; Gregoire J; Renaud MC; Ghani K; Têtu B; Bairati I; Bachvarov D
    Mol Oncol; 2011 Oct; 5(5):438-53. PubMed ID: 21856257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory role of prohibitin in human ovarian epithelial cancer.
    Jia L; Ren JM; Wang YY; Zheng Y; Zhang H; Zhang Q; Kong BH; Zheng WX
    Int J Clin Exp Pathol; 2014; 7(5):2247-55. PubMed ID: 24966933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.